FPGEE for National Association of Boards of Pharmacy (NABP) Practice Exam

In pharmacoeconomic analyses, CEA stands for Cost-Effectiveness Analysis. This method evaluates the economic value of healthcare interventions by comparing the costs and outcomes associated with different treatments. The key aspect of CEA is that it assesses the cost of delivering healthcare relative to the effectiveness of the treatment in improving patient outcomes, often measured in quality-adjusted life years (QALYs) or life years gained.

Cost-Effectiveness Analysis is a crucial tool in healthcare decision-making as it helps determine which interventions provide the best value for the resources invested, guiding policymakers, healthcare providers, and patients in making informed choices. By quantifying both costs and health outcomes, CEA allows for a systematic comparison of various medical treatments and interventions, ensuring resources are allocated efficiently and effectively to maximize health benefits.